Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bcl-2 does not require Raf kinase activity for its death-protective function

R Olivier1, I Otter, L Monney

  • 1Institute of Biochemistry, University of Fribourg, Rue du Musee 5, CH-1700 Fribourg.

The Biochemical Journal
|May 15, 1997
PubMed
Summary

The oncogene bcl-2 (B-cell lymphoma 2) prevents cell death but does not require c-raf-1 kinase activity. This finding challenges the hypothesis that bcl-2 uses raf-dependent pathways for its survival function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lifespan of a bicanalicular nasolacrimal silicone stent.

Journal francais d'ophtalmologie·2020
Same author

The problem of stray dogs.

Revue scientifique et technique (International Office of Epizootics)·2019
Same author

Unsymmetrical diborane(4) derivatives by copper mediated B-B coupling.

Dalton transactions (Cambridge, England : 2003)·2018
Same author

The clerodane diterpene casearin J induces apoptosis of T-ALL cells through SERCA inhibition, oxidative stress, and interference with Notch1 signaling.

Cell death & disease·2016
Same author

9th Tuscany Retreat on Cancer Research: genetic profiling, resistance mechanisms and novel treatment concepts in cancer.

Cell death and differentiation·2015
Same author

Selective B-B bond activation in an unsymmetrical diborane(4) by [(Me₃P)₄Rh-X] (X = Me, OtBu): a switch of mechanism?

Dalton transactions (Cambridge, England : 2003)·2015

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The oncogene bcl-2 (B-cell lymphoma 2) is known to inhibit apoptosis (programmed cell death) in mammalian cells.
  • The precise molecular mechanisms and signaling pathways targeted by bcl-2 remain incompletely understood.
  • Previous in vitro studies suggested bcl-2 interacts with c-raf-1, proposing a raf-dependent signaling pathway for bcl-2's death-suppressive function.

Purpose of the Study:

  • To investigate the role of c-raf-1 kinase activity in mediating the anti-apoptotic function of bcl-2.
  • To determine if bcl-2 stably associates with c-raf-1 in cellular extracts.
  • To test the hypothesis that bcl-2 requires raf-dependent signal transduction for cell-death protection.

Main Methods:

  • Immunological assays

Related Experiment Videos

  • Biochemical methods
  • Analysis of cellular extracts from fibroblasts
  • Overexpression of kinase-defective raf mutants

    • Main Results:

    • bcl-2 does not stably associate with c-raf-1 in cellular extracts, even after induction of apoptosis.
    • The survival function of bcl-2 is maintained or enhanced when raf-dependent signaling is inhibited.
    • bcl-2 can support the stable overexpression of a dominant-negative raf mutant that typically impairs cell viability.

    Conclusions:

    • bcl-2 does not require c-raf-1 kinase activity or the associated mitogen-activated protein kinase (MAPK) pathway for its cell survival function.
    • These findings decouple bcl-2's anti-apoptotic role from raf-dependent signaling.
    • This dissociation offers opportunities to dissect cellular events independently of c-raf-1 kinase activity.